GONARELIX 0.25 MG INJECTION
Prescription Required
Product introduction
GONARELIX 0.25 MG INJECTION is an anti-gonadotropin-releasing hormone medicine. It is used in the treatment of infertility in females. It restricts eggs to release directly and prevents premature ovulation.
GONARELIX 0.25 MG INJECTION is used during techniques in women that help them in getting pregnant
GONARELIX 0.25 MG INJECTION is used during techniques in women that help them in getting pregnant
Uses of Gonarelix Injection
Benefits of Gonarelix Injection
In Female infertility
GONARELIX 0.25 MG INJECTION prevents release of premature eggs during a process called ovulation in females. This helps in normal development of an egg in a woman's ovary (female reproductive organ), and stimulates the release of a healthy, matured egg. This helps to treat infertility in women and increases the chance of a successful pregnancy. It is given as an injection by a doctor or nurse and should not be self-administered. You should use the medicine as prescribed for it to be effective.
Side effects of Gonarelix Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Gonarelix
- Injection site reaction
- Headache
- Nausea
- Ovarian hyperstimulation syndrome
- Abdominal pain
- Vaginal bleeding
How to use Gonarelix Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with GONARELIX 0.25 MG INJECTION. Please consult your doctor.
Pregnancy
UNSAFE
GONARELIX 0.25 MG INJECTION is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
UNSAFE
GONARELIX 0.25 MG INJECTION is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether GONARELIX 0.25 MG INJECTION alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
CAUTION
GONARELIX 0.25 MG INJECTION should be used with caution in patients with kidney disease. Dose adjustment of GONARELIX 0.25 MG INJECTION may be needed. Please consult your doctor.
Use of GONARELIX 0.25 MG INJECTION is not advised in patients with moderate to severe kidney disease patients.
Use of GONARELIX 0.25 MG INJECTION is not advised in patients with moderate to severe kidney disease patients.
Liver
CAUTION
GONARELIX 0.25 MG INJECTION should be used with caution in patients with liver disease. Dose adjustment of GONARELIX 0.25 MG INJECTION may be needed. Please consult your doctor.
Use of GONARELIX 0.25 MG INJECTION is not advised in patients with moderate to severe liver disease patients.
Use of GONARELIX 0.25 MG INJECTION is not advised in patients with moderate to severe liver disease patients.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
GONARELIX 0.25 MG INJECTION
₹1090/Injection
Orgalutran 0.25mg Injection
Organon (India) Ltd
₹2382/injection
9% costlier
Quick tips
- GONARELIX 0.25 MG INJECTION helps prevent premature ovulation in women undergoing assisted reproduction treatments such as IVF.
- It is injected under the skin (subcutaneously), preferably of the upper leg.
- Inform your doctor immediately if you get very dizzy, faint, vomit, or have diarrhea while using this medicine. These could be symptoms of ovarian hyperstimulation syndrome (OHSS).
- Do not use this medicine if you are already pregnant or breastfeeding.
Fact Box
Chemical Class
Polypeptides
Habit Forming
No
Therapeutic Class
HORMONES
Action Class
GNRH antagonists
Patient concerns
FAQs
What is GONARELIX 0.25 MG INJECTION and what it is used for?
GONARELIX 0.25 MG INJECTION is an injectable preparation, which contains the active substance Ganirelix. It is used in women undergoing certain fertility treatments. It acts by blocking the release of luteinizing hormone (LH), thus preventing the early release of eggs and giving them the time to grow properly.
How and in what dose can it be used?
It is given as an injection, only at a hospital or clinic by a medical healthcare professional. The patient may be monitored regularly for the follicular development. The treatment duration depends on the ovarian response of the patient.
Does GONARELIX 0.25 MG INJECTION stop follicle growth?
No, GONARELIX 0.25 MG INJECTION does not slow or stop follicle growth
Does GONARELIX 0.25 MG INJECTION stop/ prevent ovulation?
No, GONARELIX 0.25 MG INJECTION does not stop or prevent ovulation. It reduces luteinizing hormone (LH) surge in women suffering from premature ovulation or undergoing a controlled ovarian stimulation for assisted reproduction technique (like IVF).
What are the possible side effects associated with it?
The most common side effect is local site reaction (redness of skin with or without swelling). You may also experience headache or nausea. However, these effects are temporary. If these persist consult your doctor. In addition, conditions like ovarian hyperstimulation syndrome (OHSS), and multiple births or birth defect may also be associated with the use of this medicine.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 655.
- EMEA. Ganirelix. [Accessed 03 Apr. 2019] (online) Available from:
- Ganirelix. Ravensburg, Germany: Vetter Pharma-Fertigung GmbH & Co. [Accessed 03 Apr. 2019] (online) Available from:
Marketer details
Name: Sun Pharmaceutical Industries Ltd
Address: Plot no 107/108,Namli block , Ranipool, East Sikkim 737135
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present